Sonova raises FY 2026/27 core EBIT growth outlook to 10%-13% in local currencies
- Sonova raised fiscal 2026/27 core EBIT growth guidance to 10%-13% in local currencies from 7%-10%.
- Sales growth is now forecast at 6%-8% in local currencies, versus 5%-8% previously.
- Global hearing care market growth is expected at 3%-5%, up from 2%-4%, reflecting a recent recovery.
- First-half sales rose 7.5% in local currencies; core EBIT increased 22.9%, with its margin expanding 260 basis points.
- The EON launch is expected to support further market share gains, while Integro should support a second-half cochlear implants recovery.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonova Holding AG published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.